Operating to remove recurrent colorectal cancer: have we got it right?

BMJ. 2014 May 13:348:g2085. doi: 10.1136/bmj.g2085.

Authors

Tom Treasure¹, Kathryn Monson², Francesca Fiorentino³, Christopher Russell⁴

Affiliations

¹ University College London Clinical Operational Research Unit, London, UK tom.treasure@gmail.com.
² Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, UK.
³ Imperial College, Cardiothoracic Surgery Department, London, UK.
⁴ London, UK.

PMID: 25134098
DOI: 10.1136/bmj.g2085

No abstract available

MeSH terms

Biomarkers, Tumor / metabolism
Carcinoembryonic Antigen / metabolism*
Colorectal Neoplasms / pathology
Colorectal Neoplasms / surgery*
Humans
Liver Neoplasms / secondary
Liver Neoplasms / surgery*
Lung Neoplasms / secondary
Lung Neoplasms / surgery*
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / surgery*
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Reoperation
Second-Look Surgery*

Substances

Biomarkers, Tumor
Carcinoembryonic Antigen